ARCHIVES

In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers

This article is from The Cancer Letter archive.

Vol. 22 No. 38 | October 4, 1996

Download PDF Visit The Full Archive

Related Articles

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

March 2, 2001

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

October 21, 2005

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011